Nomura Adjusts RemeGen's Price Target to 27.82 Yuan From 52.87, Keeps at Neutral
Nomura Adjusts RemeGen's Price Target to 27.82 Yuan From 52.87, Keeps at Neutral
野村将荣昌生物的目标价从52.87元下调至27.82元,但维持中立评级。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册